Adrenal cortical tumors in children: Factors associated with poor outcome

Journal of Pediatric Surgery

Volumn 46, Issue 6, 2011, Pages 1201-1207

  Klein, Justin D ^a   Turner, Christopher G ^a   Gray, Fabienne L ^a   Yu, David C ^a,b   Kozakewich, Harry P ^a   Perez Atayde, Antonio R ^a   Voss, Stephan D ^a   Zurakowski, David ^a   Shamberger, Robert C ^a   Weldon, Christopher B ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenal cortical carcinoma; Outcome; Pathology; Pediatric; Prognosis; Treatment

Indexed keywords

17 OXOSTEROID; CISPLATIN; DOXORUBICIN; ETOPOSIDE; MITOTANE; TESTOSTERONE;

ADJUVANT THERAPY; ADRENAL CORTEX TUMOR; ADRENALECTOMY; ADVANCED CANCER; ARTICLE; BECKWITH WIEDEMANN SYNDROME; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CARNEY COMPLEX; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMIHYPERTROPHY; HUMAN; INFANT; MALE; METASTASIS; MITOSIS RATE; NECROSIS; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 79959288897     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2011.03.052     Document Type: Article

References (35)

1. Chudler RM, Kay R. Adrenocortical carcinoma in children. Urol Clin North Am 1989;16(3):469-79. (Pubitemid 19209755)
2. Michalkiewicz E, Sandrini R, Figueiredo B, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 2004;22(5):838-45. (Pubitemid 41103595)
3. Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A 2001;98(16):9330-5. (Pubitemid 32743916)
4. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000;88(4):711-36. (Pubitemid 30091090)
5. Cagle PT, Hough AJ, Pysher TJ, et al. Comparison of adrenal cortical tumors in children and adults. Cancer 1986;57(11):2235-7. (Pubitemid 16121763)
6. Ribeiro RC, Michalkiewicz EL, Figueiredo BC, et al. Adrenocortical tumors in children. Braz J Med Biol Res 2000;33(10):1225-34.
7. Weiss LM, Medeiros LJ, Vickery Jr AL. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989;13(3):202-6. (Pubitemid 19081702)
8. Bugg MF, Ribeiro RC, Roberson PK, et al. Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia. A study of a Brazilian population. Brazilian Group for Treatment of Childhood Adrenocortical Tumors. Am J Clin Pathol 1994;101(5):625-9. (Pubitemid 24153821)
9. Lack EE, Mulvihill JJ, Travis WD, et al. Adrenal cortical neoplasms in the pediatric and adolescent age group. Clinicopathologic study of 30 cases with emphasis on epidemiological and prognostic factors. Pathol Annu 1992;27(Pt 1):1-53.
10. Clark TG, Bradburn MJ, Love SB, et al. Survival analysis part I: basic concepts and first analyses. Br J Cancer 2003;89(2):232-8. (Pubitemid 36976306)
11. Bradburn MJ, Clark TG, Love SB, et al. Survival analysis part II: multivariate data analysis-an introduction to concepts and methods. Br J Cancer 2003;89(3):431-6. (Pubitemid 37026422)
12. Pepe MS. The statistical evaluation of medical tests for classification and prediction. New York: Oxford University Press; 2004.
13. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17(8):857-72. (Pubitemid 28185165)
14. Terzolo M, Bovio S, Pia A, et al. Management of adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 2009;23(2):233-43.
15. Sidhu S, Gicquel C, Bambach CP, et al. Clinical and molecular aspects of adrenocortical tumourigenesis. ANZ J Surg 2003;73(9):727-38. (Pubitemid 37267122)
16. Liou LS, Kay R. Adrenocortical carcinoma in children. Review and recent innovations. Urol Clin North Am 2000;27(3):403-21.
17. Barry MK, van Heerden JA, Farley DR, et al. Can adrenal incidentalomas be safely observed? World J Surg 1998;22(6):599-603 [discussion 603-594].
18. Logie A, Boulle N, Gaston V, et al. Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line. J Mol Endocrinol 1999;23(1):23-32. (Pubitemid 29369556)
19. Green DM, Breslow NE, Beckwith JB, et al. Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study. Med Pediatr Oncol 1993;21(3):188-92. (Pubitemid 23084329)
20. Boland GW, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 1998;171(1):201-4. (Pubitemid 28308675)
21. Boland GW, Blake MA, Hahn PF, et al. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 2008;249(3):756-75.
22. Hussain HK, Korobkin M. MR imaging of the adrenal glands. Magn Reson Imaging Clin N Am. Aug 2004;12(3):515-44, vii.
23. Groussin L, Bonardel G, Silvera S, et al. 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 2009;94(5):1713-22.
24. Ashcraft KW. Pediatric surgery. 3rd ed. Philadelphia: Saunders; 1999.
25. Saunders BD, Doherty GM. Laparoscopic adrenalectomy for malignant disease. Lancet Oncol 2004;5(12):718-26.
26. Hanna AM, Pham TH, Askegard-Giesmann JR, et al. Outcome of adrenocortical tumors in children. J Pediatr Surg 2008;43(5):843-9. (Pubitemid 351657538)
27. Harrison LE, Gaudin PB, Brennan MF. Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 1999;134(2):181-5. (Pubitemid 29088971)
28. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984;8(3):163-9. (Pubitemid 14166767)
29. Morimoto R, Satoh F, Murakami O, et al. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocr J 2008;55(1):49-55. (Pubitemid 351520179)
30. Giordano TJ, Kuick R, Else T, et al. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 2009;15(2):668-76.
31. Dehner LP, Hill DA. Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors? Pediatr Dev Pathol 2009;12(4):284-91.
32. Huang H, Fojo T. Adjuvant mitotane for adrenocortical cancer - a recurring controversy. J Clin Endocrinol Metab 2008;93(10):3730-2.
33. Hahner S, Fassnacht M. Mitotane for adrenocortical carcinoma treatment. Curr Opin Investig Drugs 2005;6(4):386-94. (Pubitemid 40561415)
34. First International Randomized trial in locally advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT). http://www.firm-act.org/.
35. Fassnacht M, Hahner S, Polat B, et al. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab 2006;91(11):4501-4. (Pubitemid 44833430)